Adult stem cell products could be lining up to penetrate the inflammation and orthopedics markets, judging by the recent $1.38 billion paid by Genzyme for Osiris's mesenchymal stem cell technology.

The European Commission has said that the first list of STEP Seals will promote top-quality projects relating to strategic ...